Apeloa Pharmaceutical Co.,Ltd
000739.SZ · SHZ
Market closed19.65-1.35 (-6.43%)
Key statistics
Previous close21.00
Open20.55
Day high21.20
Day low19.47
52-week high21.50
52-week low14.71
Market cap22.76B
Volume35.78M
Average volume13.99M
P/E ratio27.50
Forward P/E—
EPS0.71
Dividend yield+2.98%
Market context
Why it moved
In the absence of directly relevant news, 000739.SZ (Anning Chemical Industry) likely fell sharply today due to broad selling pressure in the Chinese chemical sector amid weakening demand outlook and broader market risk-off sentiment.
What is happening
Recent company-specific developments and publisher coverage.
finance.biggo.com · March 19, 2026Apeloa's 2025 Revenue and Net Profit Both Decline; CDMO Business Emerges as Sole Bright Spot with Nearly 17% Growth Against the TrendContract Pharma · October 30, 2025Apeloa Pharmaceutical Passes 20th FDA InspectionGlobeNewswire · August 27, 2025Hengdian Group’s Apeloa Pharmaceutical uses Flow Chemistry for sustainable manufacturingGenerics and Biosimilars Initiative · April 22, 2022Five Chinese companies join UN’s MPP for Covid-19 medicines Mt Newswire · July 17, 2026Apeloa Pharmaceutical to Set Up 10 Million Yuan Joint Venture Mt Newswire · May 29, 2026Apeloa Pharmaceutical's Unit Gets EU Certificate for Amantadine Hydrochloride Mt Newswire · May 22, 2026Apeloa Pharmaceutical Gets US FDA Nod for Hypertension, Angina Treatment Mt Newswire · May 18, 2026Apeloa Pharmaceutical Subsidiary Gets China Approval for Antibiotic Mt Newswire · April 21, 2026Apeloa Pharmaceutical Q1 Profit Inches Up; Shares Rise 4% Mt Newswire · April 16, 2026Apeloa Pharmaceutical Gets China Nod for Cholesterol-Lowering Drug Mt Newswire · March 23, 2026Apeloa Pharmaceutical Gets European Suitability Certificate for Antipsychotic Mt Newswire · December 24, 2025Apeloa Pharmaceutical Gets Regulatory Nod for Antiviral Drug